Minority report: the intestinal mycobiota in systemic infections
- 27 June 2020
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Microbiology
- Vol. 56, 1-6
- https://doi.org/10.1016/j.mib.2020.05.004
Abstract
No abstract availableKeywords
Funding Information
- Geoffrey Beene Foundation
- Burroughs Wellcome Fund
- National Institutes of Health (P30 CA008748, R01 AI093808, R01 AI 139632)
- Deutsche Forschungsgemeinschaft (RO5328/2-1)
This publication has 51 references indexed in Scilit:
- Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile InfectionAntimicrobial Agents and Chemotherapy, 2013
- The Variability of the 16S rRNA Gene in Bacterial Genomes and Its Consequences for Bacterial Community AnalysesPLOS ONE, 2013
- Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile InfectionClinical Infectious Diseases, 2012
- Human gut microbiome viewed across age and geographyNature, 2012
- OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile InfectionAntimicrobial Agents and Chemotherapy, 2009
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis , Candida orthopsilosis , and Candida metapsilosis Accounts for Reduced Echinocandin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- Mucosal Damage and Neutropenia Are Required for Candida albicans DisseminationPLoS Pathogens, 2008
- Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated DiarrheaThe Journal of Infectious Diseases, 2008
- Revisiting the Source of Candidemia: Skin or Gut?Clinical Infectious Diseases, 2001
- FUNGÆMIA AND FUNGURIA AFTER ORAL ADMINISTRATION OF CANDIDA ALBICANSThe Lancet, 1969